# The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.

> **NCT00156169** · PHASE3 · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Low HDL Cholesterol

## Interventions

- **DRUG:** Dunaliella

## Key facts

- **NCT ID:** NCT00156169
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156169, "The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00156169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*